Status: Recruiting
Melodi Matrix™ in Breast Reconstruction
Prospective, multicenter, randomized, controlled trial evaluating the safety and effectiveness of an absorbable antibacterial matrix device in two stage prepectoral alloplastic breast reconstruction.
Participants needed: 702
Trial details
Age: 22+Biological sex: FemaleType: InterventionalSponsor: Melodi Health, Inc.Updated: Dec 8, 2025Locations: 10
Eligibility criteria
Female. [+3]
Has prior history of neoadjuvant radiotherapy. [+10]